Literature DB >> 22044755

Gene expression profiles of breast biopsies from healthy women identify a group with claudin-low features.

Vilde D Haakensen1, Ole Christian Lingjaerde, Torben Lüders, Margit Riis, Aleix Prat, Melissa A Troester, Marit M Holmen, Jan Ole Frantzen, Linda Romundstad, Dina Navjord, Ida K Bukholm, Tom B Johannesen, Charles M Perou, Giske Ursin, Vessela N Kristensen, Anne-Lise Børresen-Dale, Aslaug Helland.   

Abstract

BACKGROUND: Increased understanding of the variability in normal breast biology will enable us to identify mechanisms of breast cancer initiation and the origin of different subtypes, and to better predict breast cancer risk.
METHODS: Gene expression patterns in breast biopsies from 79 healthy women referred to breast diagnostic centers in Norway were explored by unsupervised hierarchical clustering and supervised analyses, such as gene set enrichment analysis and gene ontology analysis and comparison with previously published genelists and independent datasets.
RESULTS: Unsupervised hierarchical clustering identified two separate clusters of normal breast tissue based on gene-expression profiling, regardless of clustering algorithm and gene filtering used. Comparison of the expression profile of the two clusters with several published gene lists describing breast cells revealed that the samples in cluster 1 share characteristics with stromal cells and stem cells, and to a certain degree with mesenchymal cells and myoepithelial cells. The samples in cluster 1 also share many features with the newly identified claudin-low breast cancer intrinsic subtype, which also shows characteristics of stromal and stem cells. More women belonging to cluster 1 have a family history of breast cancer and there is a slight overrepresentation of nulliparous women in cluster 1. Similar findings were seen in a separate dataset consisting of histologically normal tissue from both breasts harboring breast cancer and from mammoplasty reductions.
CONCLUSION: This is the first study to explore the variability of gene expression patterns in whole biopsies from normal breasts and identified distinct subtypes of normal breast tissue. Further studies are needed to determine the specific cell contribution to the variation in the biology of normal breasts, how the clusters identified relate to breast cancer risk and their possible link to the origin of the different molecular subtypes of breast cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22044755      PMCID: PMC3216859          DOI: 10.1186/1755-8794-4-77

Source DB:  PubMed          Journal:  BMC Med Genomics        ISSN: 1755-8794            Impact factor:   3.063


  38 in total

1.  Significance analysis of microarrays applied to the ionizing radiation response.

Authors:  V G Tusher; R Tibshirani; G Chu
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

2.  Expression profiling of epithelial plasticity in tumor progression.

Authors:  Martin Jechlinger; Stefan Grunert; Ido H Tamir; Elzbieta Janda; Susanna Lüdemann; Thomas Waerner; Peter Seither; Andreas Weith; Hartmut Beug; Norbert Kraut
Journal:  Oncogene       Date:  2003-10-16       Impact factor: 9.867

3.  Adjustment of systematic microarray data biases.

Authors:  Monica Benito; Joel Parker; Quan Du; Junyuan Wu; Dong Xiang; Charles M Perou; J S Marron
Journal:  Bioinformatics       Date:  2004-01-01       Impact factor: 6.937

4.  Reliability and reproducibility of gene expression measurements using amplified RNA from laser-microdissected primary breast tissue with oligonucleotide arrays.

Authors:  Chialin King; Ning Guo; Garrett M Frampton; Norman P Gerry; Marc E Lenburg; Carol L Rosenberg
Journal:  J Mol Diagn       Date:  2005-02       Impact factor: 5.568

Review 5.  Epithelial stem cells and their niche: there's no place like home.

Authors:  Adnan Z Rizvi; Melissa H Wong
Journal:  Stem Cells       Date:  2005-02       Impact factor: 6.277

6.  The detection of changes in mammographic densities.

Authors:  G Ursin; M A Astrahan; M Salane; Y R Parisky; J G Pearce; J R Daniels; M C Pike; D V Spicer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1998-01       Impact factor: 4.254

7.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.

Authors:  T Sørlie; C M Perou; R Tibshirani; T Aas; S Geisler; H Johnsen; T Hastie; M B Eisen; M van de Rijn; S S Jeffrey; T Thorsen; H Quist; J C Matese; P O Brown; D Botstein; P E Lønning; A L Børresen-Dale
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-11       Impact factor: 11.205

8.  A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes.

Authors:  Richard M Neve; Koei Chin; Jane Fridlyand; Jennifer Yeh; Frederick L Baehner; Tea Fevr; Laura Clark; Nora Bayani; Jean-Philippe Coppe; Frances Tong; Terry Speed; Paul T Spellman; Sandy DeVries; Anna Lapuk; Nick J Wang; Wen-Lin Kuo; Jackie L Stilwell; Daniel Pinkel; Donna G Albertson; Frederic M Waldman; Frank McCormick; Robert B Dickson; Michael D Johnson; Marc Lippman; Stephen Ethier; Adi Gazdar; Joe W Gray
Journal:  Cancer Cell       Date:  2006-12       Impact factor: 31.743

9.  In situ analyses of genome instability in breast cancer.

Authors:  Koei Chin; Carlos Ortiz de Solorzano; David Knowles; Arthur Jones; William Chou; Enrique Garcia Rodriguez; Wen-Lin Kuo; Britt-Marie Ljung; Karen Chew; Kenneth Myambo; Monica Miranda; Sheryl Krig; James Garbe; Martha Stampfer; Paul Yaswen; Joe W Gray; Stephen J Lockett
Journal:  Nat Genet       Date:  2004-08-08       Impact factor: 38.330

10.  Expression profiling of purified normal human luminal and myoepithelial breast cells: identification of novel prognostic markers for breast cancer.

Authors:  Chris Jones; Alan Mackay; Anita Grigoriadis; Antonio Cossu; Jorge S Reis-Filho; Laura Fulford; Tim Dexter; Susan Davies; Karen Bulmer; Emily Ford; Suzanne Parry; Mario Budroni; Giuseppe Palmieri; A Munro Neville; Michael J O'Hare; Sunil R Lakhani
Journal:  Cancer Res       Date:  2004-05-01       Impact factor: 12.701

View more
  27 in total

1.  A Longitudinal Study of the Association between Mammographic Density and Gene Expression in Normal Breast Tissue.

Authors:  Helga Bergholtz; Tonje Gulbrandsen Lien; Giske Ursin; Marit Muri Holmen; Åslaug Helland; Therese Sørlie; Vilde Drageset Haakensen
Journal:  J Mammary Gland Biol Neoplasia       Date:  2019-01-06       Impact factor: 2.673

2.  Glycan-related gene expression signatures in breast cancer subtypes; relation to survival.

Authors:  Ivan O Potapenko; Torben Lüders; Hege G Russnes; Åslaug Helland; Therese Sørlie; Vessela N Kristensen; Silje Nord; Ole C Lingjærde; Anne-Lise Børresen-Dale; Vilde D Haakensen
Journal:  Mol Oncol       Date:  2015-01-14       Impact factor: 6.603

3.  Molecular profiling of human mammary gland links breast cancer risk to a p27(+) cell population with progenitor characteristics.

Authors:  Sibgat Choudhury; Vanessa Almendro; Vanessa F Merino; Zhenhua Wu; Reo Maruyama; Ying Su; Filipe C Martins; Mary Jo Fackler; Marina Bessarabova; Adam Kowalczyk; Thomas Conway; Bryan Beresford-Smith; Geoff Macintyre; Yu-Kang Cheng; Zoila Lopez-Bujanda; Antony Kaspi; Rong Hu; Judith Robens; Tatiana Nikolskaya; Vilde D Haakensen; Stuart J Schnitt; Pedram Argani; Gabrielle Ethington; Laura Panos; Michael Grant; Jason Clark; William Herlihy; S Joyce Lin; Grace Chew; Erik W Thompson; April Greene-Colozzi; Andrea L Richardson; Gedge D Rosson; Malcolm Pike; Judy E Garber; Yuri Nikolsky; Joanne L Blum; Alfred Au; E Shelley Hwang; Rulla M Tamimi; Franziska Michor; Izhak Haviv; X Shirley Liu; Saraswati Sukumar; Kornelia Polyak
Journal:  Cell Stem Cell       Date:  2013-06-13       Impact factor: 24.633

4.  Metalloproteinase-disintegrin ADAM12 is associated with a breast tumor-initiating cell phenotype.

Authors:  Hui Li; Sara Duhachek-Muggy; Suzanne Dubnicka; Anna Zolkiewska
Journal:  Breast Cancer Res Treat       Date:  2013-06-16       Impact factor: 4.872

5.  The glutathione peroxidase 8 (GPX8)/IL-6/STAT3 axis is essential in maintaining an aggressive breast cancer phenotype.

Authors:  Anees Khatib; Balakrishnan Solaimuthu; Michal Ben Yosef; Areej Abu Rmaileh; Mayur Tanna; Gidi Oren; Michal Schlesinger Frisch; Jonathan H Axelrod; Michal Lichtenstein; Yoav D Shaul
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-18       Impact factor: 11.205

6.  Breast Cancer beyond the Age of Mutation.

Authors:  Mark A LaBarge; E Lorena Mora-Blanco; Susan Samson; Masaru Miyano
Journal:  Gerontology       Date:  2015-11-06       Impact factor: 5.140

7.  A high capacity polymeric micelle of paclitaxel: Implication of high dose drug therapy to safety and in vivo anti-cancer activity.

Authors:  Zhijian He; Xiaomeng Wan; Anita Schulz; Herdis Bludau; Marina A Dobrovolskaia; Stephan T Stern; Stephanie A Montgomery; Hong Yuan; Zibo Li; Daria Alakhova; Marina Sokolsky; David B Darr; Charles M Perou; Rainer Jordan; Robert Luxenhofer; Alexander V Kabanov
Journal:  Biomaterials       Date:  2016-06-04       Impact factor: 12.479

8.  Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression.

Authors:  Hatef Darabi; Karen McCue; Jonathan Beesley; Kyriaki Michailidou; Silje Nord; Siddhartha Kar; Keith Humphreys; Deborah Thompson; Maya Ghoussaini; Manjeet K Bolla; Joe Dennis; Qin Wang; Sander Canisius; Christopher G Scott; Carmel Apicella; John L Hopper; Melissa C Southey; Jennifer Stone; Annegien Broeks; Marjanka K Schmidt; Rodney J Scott; Artitaya Lophatananon; Kenneth Muir; Matthias W Beckmann; Arif B Ekici; Peter A Fasching; Katharina Heusinger; Isabel Dos-Santos-Silva; Julian Peto; Ian Tomlinson; Elinor J Sawyer; Barbara Burwinkel; Frederik Marme; Pascal Guénel; Thérèse Truong; Stig E Bojesen; Henrik Flyger; Javier Benitez; Anna González-Neira; Hoda Anton-Culver; Susan L Neuhausen; Volker Arndt; Hermann Brenner; Christoph Engel; Alfons Meindl; Rita K Schmutzler; Norbert Arnold; Hiltrud Brauch; Ute Hamann; Jenny Chang-Claude; Sofia Khan; Heli Nevanlinna; Hidemi Ito; Keitaro Matsuo; Natalia V Bogdanova; Thilo Dörk; Annika Lindblom; Sara Margolin; Veli-Matti Kosma; Arto Mannermaa; Chiu-Chen Tseng; Anna H Wu; Giuseppe Floris; Diether Lambrechts; Anja Rudolph; Paolo Peterlongo; Paolo Radice; Fergus J Couch; Celine Vachon; Graham G Giles; Catriona McLean; Roger L Milne; Pierre-Antoine Dugué; Christopher A Haiman; Gertraud Maskarinec; Christy Woolcott; Brian E Henderson; Mark S Goldberg; Jacques Simard; Soo H Teo; Shivaani Mariapun; Åslaug Helland; Vilde Haakensen; Wei Zheng; Alicia Beeghly-Fadiel; Rulla Tamimi; Arja Jukkola-Vuorinen; Robert Winqvist; Irene L Andrulis; Julia A Knight; Peter Devilee; Robert A E M Tollenaar; Jonine Figueroa; Montserrat García-Closas; Kamila Czene; Maartje J Hooning; Madeleine Tilanus-Linthorst; Jingmei Li; Yu-Tang Gao; Xiao-Ou Shu; Angela Cox; Simon S Cross; Robert Luben; Kay-Tee Khaw; Ji-Yeob Choi; Daehee Kang; Mikael Hartman; Wei Yen Lim; Maria Kabisch; Diana Torres; Anna Jakubowska; Jan Lubinski; James McKay; Suleeporn Sangrajrang; Amanda E Toland; Drakoulis Yannoukakos; Chen-Yang Shen; Jyh-Cherng Yu; Argyrios Ziogas; Minouk J Schoemaker; Anthony Swerdlow; Anne-Lise Borresen-Dale; Vessela Kristensen; Juliet D French; Stacey L Edwards; Alison M Dunning; Douglas F Easton; Per Hall; Georgia Chenevix-Trench
Journal:  Am J Hum Genet       Date:  2015-06-11       Impact factor: 11.025

9.  Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients.

Authors:  Erick Román-Pérez; Patricia Casbas-Hernández; Jason R Pirone; Jessica Rein; Lisa A Carey; Ronald A Lubet; Sendurai A Mani; Keith D Amos; Melissa A Troester
Journal:  Breast Cancer Res       Date:  2012-03-19       Impact factor: 6.466

10.  Caveolin-1 expression is elevated in claudin-low mammary tumor cells.

Authors:  Devan E Thompson; Megan D Siwicky; Roger A Moorehead
Journal:  Cancer Cell Int       Date:  2012-02-22       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.